7/28/2022, 12:31 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Merck & Co Inc

Merck: EPS more than triples to $1.55 in Q2

Merck & Co. Inc. said on Thursday that its GAAP earnings per share (EPS) from continuing operations for the second quarter of fiscal 2022 stood at $1.55, up 223% from the same period a year ago.

The pharmaceutical company from New Jersey also revealed that its sales in the second trimester totaled $14.6 billion, representing a 28% jump year-on-year, while its GAAP net income surged 225% on an annual basis to reach $3.9 billion.

"I am very confident that we are well-positioned to achieve our near- and long-term goals, anchored by our commitment to deliver innovative medicines and vaccines to patients and value to all of our stakeholders, including shareholders," CEO and President Robert Davis said in the press release.

Company shares decreased 0.08% in the premarket following the release of the report.

Baha Breaking News (BBN) / MS